Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein

Urological Research

Volumn 25, Issue 1, 1997, Pages 35-42

  Siegsmund, M J ^a   Kreukler, C ^a   Steidler, A ^a   Nebe, T ^a   Kohrmann K U ^a   Alken, P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

androgen independent; Dunning tumor; mdr1b gene; multidrug resistance; prostate cancer

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; METHOTREXATE; PACLITAXEL; VERAPAMIL; VINBLASTINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; RAT;

EID: 0030937267     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00941904     Document Type: Article

References (35)

1. Akman SA, Forrest G, Chu FF, Esworthy RS, Doroshow JH (1990) Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells. Cancer Res 50:1397
2. Bhushan A, Abramson R, Chiu JF, Tritton TR (1992) Expression of c-fos in human and murine multidrug-resistant cells. Mol Pharmacol 42:69
3. Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaronson SA, Kruh GD (1995) Expression of multidrug resistance-associated protein in N1H/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 55:5342
4. Buttyan R, Zaken Z, Lockshin R, Wogemuth D (1988) Cascade induction of c-fos, c-myc and heat shock 70k transcripts during regression of the rat ventral prostate gland. Mol Endocrinol 2:650
5. Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M (1988) The c-fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54:541
6. Chomzynzki P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 167:156
7. Cole SPC, Downes HF, Slovak ML (1989) Effects of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein. Br J Cancer 59:42
8. Doroshow JH, Akman S, Esworthy S, Chu FF, Burke T (1991) Doxorubicin resistance conferred by selective enhancement of intracellular glutathione peroxidase or superoxide dismutase content. Free Radical Res Commun 12-13:779
9. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84: 265
10. Goldstein LJ, Galski H, Fojo A, Willingham MC, Lai S-L, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Grant C, Lieber M, Cossman J, Gottesman MM, Pastan I (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116
11. Gottesman MM (1993) How cancer cells evade chemotherapy Sixteenth Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 53:747
12. Gottesman MM, Pastan I (1993) The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann Rev Biochem 62: 385
13. Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A (1995) Distant metastases from prostate carcinoma express androgen receptor protein. Cancer Res 55:3068
14. Holzmayer TA, Hilsenbeck S, Von Hoff DD, Roninson IB (1992) Clinical correlates of MDR 1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas. J Natl Cancer Inst 84:1486
15. Huff AC, Ward RE, Kreuzer KN (1990) Mutational alteration of the breakage/resealing subunit of bacteriophage T4 topoisomerase confers resistance to antitumour agent m-AMSA. Mol Gen Genet 221:27
16. Hsu SI, Cohen D, Kirschner LS, Lothstein L, Hartstein M, Horwitz SB (1990) Structural analysis of the mouse mdr 1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug resistant J 774.2 cells. Mol Cell Biol 10:3569
17. Isaacs JT, Isaacs WB, Feitz WFJ, Scheres J (1986) Establish-ment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. The Prostate 9:261
18. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS (1988) Overexpression of metallothionein confers resistance to anticancer drugs. Science (Washington DC) 241:1813.
19. Leger JG, Montpetit ML, Tenniswood MP (1987) Characterization and cloning of androgen repressed mRNAs from rat ventral prostate. Biochem Biophys Res Commun 196
20. Mickisch GH, Merlino GT, Galski H, Gottesman MM, Pastan I (1991) Transgenic mice that express the human multidrug resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc Natl Acad Sci USA 88: 547
21. Nooter K, Oostrum R, Deurloo J (1987) Effects of verapamil on the pharmacokinetics of daunomycin in the rat. Cancer Chemother Pharmacol 20:176
22. Scanlon KJ, Ishida H, Kashani-Sabet M (1994) Ribozyme-mediated reversal of the multidrug-resistant phenotype. Proc Natl Acad Sci U S A 91:11123
23. Shinoda H, Inaba M, Tsuruo T(1989) In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52. Cancer Res 49:1722
24. Siegsmund MJ, Cardarelli C, Aksentijevich I, Pastan I, Gottesmann MM (1994) Ketoconazol effectively reverses multidrug resistance in highly resistant KB cells. J Urol 151:485
25. Slater LM, Sweet P, Stupecky M, Wetzel MW, Gupta S (1986) Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma. Br J Cancer 54:235
26. Thew KD (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54:4313
27. Theyer G, Schirmböck M, Thalhammer T, Sherwood ER, Baumgartner G. Hamilton G (1993) Role of the MDR-1 encoded multiple drug resistance phenotype in prostate cancer cell lines. J Urol 1544
28. Timmer-Bosscha H, Timmer A, Meijer C, de Vries EG, de Jong B, Oosterhuis JW, Mulder NH (1993) Cid-diamminedichloroplatinum(ii) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Res 53:5707
29. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967
30. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1982) Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res 42:4730
31. Twentyman PR (1988) Modification of cytotoxic drug resistance by non-immunosuppressive cyclosporins. Br J Cancer 58:254
32. Van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CCJ, Mulder E, Boersma W, Trapman J (1991) Androgen receptors in endocrine therapy-resistant human prostate cancer. Int J Cancer 48:189
33. Van der Valk P, van Kalken CK, Ketelaars H, Broxterman HJ, Scheffer G, Kuiper CM, Tsuruo T, Lankelma J, Meijer CJLM, Pinedo HM, Scheper RJ (1990) Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Ann Oncol 1:56
34. Weißbach L, Rübben H, Jellinghaus W (1989) Die Chemotherapie des Prostatakarzinoms. In: Nagel R (ed) Aktuelle Standortbestimmung der konservativen Therapie des Prostatakarzinoms. De Gruyter, Berlin p 175
35. Yagoda A, Petrylak D (1993) Cytotoxic chemotherapy for advanced hormone -resistant prostate cancer. Cancer 71: 1098